Inactive Instrument
Sector Active Biotech AB Xetra
Stocks
BTPC
SE0001137985
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 07-25 | Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis | CI |
| 07-24 | Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.21% | +25.62% | +33.26% | +51.07% | +78.00% | +77.96% | +111.62% | +13.00% | - | 68.12B | |
| +0.50% | +6.20% | +0.42% | +10.97% | +7.00% | +38.65% | +67.83% | +189.00% | +5,543.86% | 55.18B | |
| +3.16% | +35.25% | +15.17% | +28.16% | -23.49% | +17.95% | +486.05% | +450.43% | +1,064.92% | 28.63B | |
| +0.57% | +19.05% | +24.45% | +41.21% | +46.69% | +57.08% | +5.18% | -63.25% | - | 23.99B | |
| -0.80% | +1.08% | +1.92% | -0.10% | -2.05% | -14.65% | -11.58% | -77.61% | - | 23.53B | |
| -0.35% | +7.91% | +6.61% | +20.07% | -1.73% | +46.74% | -22.61% | -30.59% | +70.69% | 18.45B | |
| -2.04% | +9.24% | +11.26% | +18.18% | +34.75% | +31.14% | +650.71% | - | - | 16.44B | |
| +7.26% | +25.47% | +3.50% | +103.78% | +213.90% | +221.03% | +383.67% | +1,621.59% | +797.11% | 15.83B | |
| -2.08% | -4.40% | -6.84% | +5.88% | +20.09% | +40.70% | +148.87% | +205.84% | +407.57% | 13.4B | |
| +1.03% | +2.86% | +15.80% | +13.80% | +33.26% | +414.06% | +205.38% | +44.54% | +1,417.50% | 12.38B | |
| +0.91% | +6.55% | -4.31% | +3.33% | -11.81% | +46.94% | +199.09% | +502.50% | +6,802.82% | 11.78B | |
| +1.50% | +8.04% | +7.24% | -24.25% | -10.18% | -36.72% | +194.63% | +111.90% | - | 11.74B | |
| +5.27% | +11.92% | -4.26% | -21.76% | -16.52% | -48.32% | +720.22% | +80.25% | +118.89% | 11.14B | |
| +0.73% | +0.10% | -9.83% | +2.64% | +20.44% | +130.30% | +135.55% | +139.68% | +531.96% | 10.67B | |
| -1.74% | +3.67% | +3.42% | -13.25% | +17.71% | +30.99% | +117.59% | -13.30% | - | 9.26B | |
| +0.62% | +10.81% | +7.62% | +37.63% | +221.09% | +589.77% | +701.75% | -34.05% | -8.52% | 9.25B | |
| +0.12% | +0.57% | +0.79% | +130.48% | +80.97% | +207.67% | +401.73% | +378.64% | - | 8.92B | |
| +0.74% | +9.29% | +0.51% | +8.36% | +26.80% | +97.19% | +23.27% | +130.61% | - | 8.64B | |
| -1.64% | +5.45% | -8.27% | -7.03% | +280.81% | +205.26% | +334.58% | -34.03% | - | 8.1B | |
| Average | +0.77% | +8.13% | +5.18% | +21.54% | +53.46% | +113.35% | +255.45% | +200.84% | +1,674.68% | 19.23B | |
| Weighted average by Cap. | +1.32% | +9.87% | +10.26% | +25.68% | +43.56% | +83.73% | +202.97% | +179.63% | +2,465.93% |
- Stock Market
- Stocks
- ACTI Stock
- BTPC Stock
- Sector Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
